Brookstone Capital Management lessened its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 90.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,920 shares of the semiconductor company's stock after selling 19,113 shares during the quarter. Brookstone Capital Management's holdings in Synopsys were worth $856,000 at the end of the most recent reporting period.
A number of other large investors have also recently made changes to their positions in SNPS. China Universal Asset Management Co. Ltd. grew its stake in shares of Synopsys by 31.8% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company's stock valued at $6,957,000 after buying an additional 3,575 shares in the last quarter. Norges Bank acquired a new position in Synopsys during the 4th quarter worth about $730,197,000. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Synopsys by 11.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 131,369 shares of the semiconductor company's stock valued at $61,707,000 after acquiring an additional 13,320 shares during the period. SBI Okasan Asset Management Co.Ltd. purchased a new position in Synopsys during the 4th quarter valued at about $1,699,000. Finally, Mizuho Markets Americas LLC acquired a new position in Synopsys in the 1st quarter valued at about $20,182,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys News Roundup
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys is expanding its use of AI in chip design, verification and simulation. These tools can improve engineering productivity and reinforce the company’s role in the semiconductor supply chain as demand for AI chips grows. Can SNPS Leverage AI to Accelerate Chip Design and Drive Growth?
- Positive Sentiment: The company is making a major push into agentic AI engineering software, developed in collaboration with Nvidia. The technology could create new growth opportunities by automating portions of chip-to-system development and strengthening Synopsys’ exposure to AI infrastructure. Synopsys Bets Big on Agentic AI
- Positive Sentiment: Despite a recent decline in the shares, analysts and market commentary continue to point to Synopsys’ recurring revenue base, AI exposure and Ansys acquisition as supports for longer-term growth. Its latest reported quarter also included revenue growth of 41.9% year over year and an earnings beat.
- Positive Sentiment: The broader Nvidia-led AI ecosystem remains a potential tailwind for Synopsys because the company provides software used to design and validate advanced chips. Nvidia’s expanding influence in AI investment and data centers could increase demand for semiconductor design tools. Nvidia Will Be the World’s First $10 Trillion Company
- Neutral Sentiment: Synopsys announced that General Counsel Janet Lee will step down, with Cor... identified as part of the transition. The leadership change may receive limited market attention unless additional details indicate an operational or governance concern. Synopsys Announces Transition of General Counsel Role
- Neutral Sentiment: An average analyst price target of $570.06 suggests substantial potential upside, but the figure does not represent a new rating or estimate revision and therefore may have limited immediate impact.
- Negative Sentiment: Wells Fargo lowered its price target from $535 to $450 and maintained an “equal weight” rating. Although the revised target remains above the recent trading level, the cut signals more cautious expectations and may weigh on sentiment. Wells Fargo Price Target Update
Wall Street Analyst Weigh In
A number of brokerages have issued reports on SNPS. Zacks Research upgraded shares of Synopsys from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, June 30th. Piper Sandler upgraded shares of Synopsys from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $450.00 to $550.00 in a report on Tuesday, June 23rd. BNP Paribas Exane upped their target price on shares of Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research note on Thursday, May 28th. Robert W. Baird set a $558.00 target price on shares of Synopsys in a report on Thursday, May 28th. Finally, Wells Fargo & Company decreased their price target on shares of Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a research report on Tuesday. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $565.06.
Read Our Latest Research Report on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company's stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.56% of the company's stock.
Synopsys Stock Up 0.3%
Synopsys stock opened at $412.32 on Thursday. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $628.89. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The stock has a market cap of $78.95 billion, a PE ratio of 95.44, a P/E/G ratio of 2.41 and a beta of 1.23. The stock's fifty day moving average is $428.15 and its two-hundred day moving average is $444.13.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion during the quarter, compared to analysts' expectations of $2.25 billion. During the same period in the prior year, the firm posted $3.67 EPS. The business's quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.65 EPS for the current fiscal year.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.